| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689325 | European Urology | 2017 | 8 Pages |
Abstract
miR-371a-3p is a novel serum marker for germ cell tumours that is expressed by 88.7% of patients and thus is far more sensitive and specific than classical serum markers. It correlates with tumour burden and treatment results. Validation in a large patient cohort is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Klaus-Peter Dieckmann, Arlo Radtke, Meike Spiekermann, Thomas Balks, Cord Matthies, Pascal Becker, Christian Ruf, Christoph Oing, Karin Oechsle, Carsten Bokemeyer, Johannes Hammel, Sebastian Melchior, Werner Wosniok, Gazanfer Belge,